 Diclofenac-associated hepatotoxicity Diclofenac sodium phenylacetic acid-derived nonsteroidal anti-inflammatory drug NSAID United development significant hepatitis patients death Signs symptoms several weeks initiation drug use weeks discontinuation use drug patient drug recurrence hepatic abnormalities patient fatal fulminant hepatitis early withdrawal drug Review European literature additional fatalities diclofenac therapy unclear incidence hepatotoxicity drug nonsteroidal anti-inflammatory drugs Careful patient monitoring prompt discontinuation drug signs symptoms liver disease develop